Disease/Infection News

RSS

New malaria vaccine strain shows promise in preclinical trials

In a report published on March 21, 2024 in EMBO Molecular Medicine (A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion) investigators at Seattle Children's Research Institute and Sanaria Inc. describe the development of a whole malaria parasite vaccine strain that infects the liver, develops to the late liver stage, and then gets completely stuck and cannot burst out of the liver to cause symptomatic blood infection.

2 Apr 2024

Physical activity lessens mental and neurological symptoms in young women during and post-COVID-19, study says

Researchers investigate the effects of physical activity on COVID-19 symptoms among young females.

2 Apr 2024

Ultra-processed foods raise chronic kidney disease risk, study shows

Consuming ultra-processed foods is linked to an 18% increased risk of chronic kidney disease, with every 10% rise in UPF intake energy contributing to a 7% greater CKD risk.

1 Apr 2024

Eating soy products linked to lower cancer risk, study finds

Soy product consumption, particularly tofu and soymilk, is linked to a reduced risk of certain cancers, highlighting the dietary factor's potential protective effect against the disease.

1 Apr 2024

AI deciphers city designs that could cut heart disease rates

AI models analyzing over half a million Google Street View images uncover urban features linked to coronary heart disease, offering insights for city design to lower disease rates.

1 Apr 2024

Climate change boosts infectious disease spread, hits the vulnerable hardest

Climate change is intensifying the spread of vector, water, and food-borne infections, disproportionately affecting vulnerable populations due to enhanced pathogen transmission in altered environmental conditions.

1 Apr 2024

Scientists develop trivalent vaccine offering broad protection against coronaviruses

Scientists have been searching for the optimal coronavirus vaccine since the Covid-19 pandemic started.

1 Apr 2024

Tuberculosis linked to increased risk of cancer, study finds

A population-wide observational study to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynaecological and colorectal cancers.

1 Apr 2024

New report on HIV drug resistance: Challenges and recommendations

The World Health Organization's (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges.

1 Apr 2024

Research suggests booster doses may be necessary for monkeypox immunity

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that even in men who receives two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.

1 Apr 2024

Study reveals waning antibody response to monkeypox vaccine over time

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination – but in people with pre-existing immunity due to childhood smallpox vaccination in childhood, antibody levels remain high in almost all cases.

1 Apr 2024

Case study: Monkeypox breakthrough infection in fully vaccinated individual

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a 'breakthrough' mpox infection in January 2024.

1 Apr 2024

Ministers of Health commit to accelerated action against malaria in Africa

Ministers of Health from African countries with the highest burden of malaria committed today to accelerated action to end deaths from the disease.

1 Apr 2024

Four years after shelter-in-place, covid-19 misinformation persists

From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.

1 Apr 2024

Irritable bowel syndrome not linked to higher Parkinson's risk, study finds

Research investigates the association between irritable bowel syndrome (IBS) and Parkinson's disease (PD), revealing that IBS is not linked to an increased overall risk of PD. Subgroup analyses suggest that certain IBS populations may have a lower risk of developing PD.

31 Mar 2024

Turning back the clock on aging immune systems: New treatment rejuvenates elderly defenses

Study demonstrated that selectively reducing myeloid-biased hematopoietic stem cells (my-HSCs) in aged mice rejuvenated the immune system, enhanced lymphopoiesis, reduced inflammation, and improved responses to viral infection, highlighting a potential strategy for countering age-related immune decline.

31 Mar 2024

Scientists identify distinct molecular signatures for sepsis diagnosis and prognosis

Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at patients who would benefit most, according to new research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).

30 Mar 2024

Introducing CoViNet: WHO's global network for coronavirus expertise

WHO has launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities for early and accurate detection, monitoring and assessment of SARS-CoV-2, MERS-CoV and novel coronaviruses of public health importance.

29 Mar 2024

WHO releases an investment case for TB screening and preventive treatment

Ahead of World Tuberculosis (TB) Day, which is marked on 24 March, WHO has released an investment case for TB screening and preventive treatment. A modeling study developed with Governments of four countries - Brazil, Georgia, Kenya and South Africa - highlights the impact to be achieved from expanding TB screening and preventive treatment.

29 Mar 2024

Global efforts urged to stem rising cholera threat

Immediate action is needed to stem an unprecedented multi-year upsurge in cholera cases worldwide, according to the International Coordinating Group (ICG) on Vaccine Provision.

28 Mar 2024